Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,282 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Prevalence of myofascial pain syndrome in patients with incurable cancer.
Ishiki H, Kinkawa J, Watanabe A, Watanabe C, Chiba T, Yasui H, Shimada N, Ariyoshi K, Nojima M, Iwase S, Tojo A, Imai K. Ishiki H, et al. Among authors: yasui h. J Bodyw Mov Ther. 2018 Apr;22(2):328-332. doi: 10.1016/j.jbmt.2017.05.005. Epub 2017 May 17. J Bodyw Mov Ther. 2018. PMID: 29861227
Monitoring ctDNA RAS Mutational Status in Metastatic Colorectal Cancer: A Trial Protocol of RAS-trace and RAS-trace-2 Studies.
Kataoka K, Yamada T, Shiozawa M, Takase N, Ito K, Yamazaki K, Watanabe J, Kudo T, Suto T, Matsumoto T, Murata K, Suwa Y, Boku S, Yasui H, Matsuhashi N, Maeda A, Sugimoto K, Matsumoto Y, Yokota M, Fredebohm J, Mori K, Ikeda M. Kataoka K, et al. Among authors: yasui h. J Anus Rectum Colon. 2024 Apr 25;8(2):132-136. doi: 10.23922/jarc.2023-051. eCollection 2024. J Anus Rectum Colon. 2024. PMID: 38689780 Free PMC article.
First-line pembrolizumab plus chemotherapy for advanced/metastatic esophageal cancer: 1-year extended follow-up in the Japanese subgroup of the phase 3 KEYNOTE-590 study.
Kato K, Kojima T, Hara H, Tsuji A, Yasui H, Muro K, Satoh T, Ogata T, Ishihara R, Goto M, Baba H, Nishina T, Han S, Iwakami K, Yatsuzuka N, Doi T. Kato K, et al. Among authors: yasui h. Esophagus. 2024 Apr 12. doi: 10.1007/s10388-024-01053-z. Online ahead of print. Esophagus. 2024. PMID: 38607538
Tumor Response Predicts Survival Time of Nivolumab Monotherapy for Advanced Gastric Cancer: A Subgroup Analysis of the DELIVER Trial (JACCRO GC-08).
Sunakawa Y, Sakamoto Y, Kawabata R, Ishiguro A, Akamaru Y, Kito Y, Takahashi M, Matsuyama J, Yabusaki H, Makiyama A, Suzuki T, Tsuda M, Yasui H, Hihara J, Takeno A, Inoue E, Ichikawa W, Fujii M. Sunakawa Y, et al. Among authors: yasui h. Oncologist. 2024 Apr 6:oyae056. doi: 10.1093/oncolo/oyae056. Online ahead of print. Oncologist. 2024. PMID: 38581687 Free article.
Feasibility study of multimodal imaging for redox status and glucose metabolism in tumor.
Kato K, Yasui H, Sato-Akaba H, Emoto MC, Fujii HG, Kmiec MM, Kuppusamy P, Mizuno Y, Kuge Y, Nagane M, Yamashita T, Inanami O. Kato K, et al. Among authors: yasui h. Free Radic Biol Med. 2024 Jun;218:57-67. doi: 10.1016/j.freeradbiomed.2024.03.028. Epub 2024 Apr 3. Free Radic Biol Med. 2024. PMID: 38574976 Free article.
1,282 results